Maravai LifeSciences Inc... (MRVI)
NASDAQ: MRVI
· Real-Time Price · USD
2.63
0.03 (1.15%)
At close: Aug 15, 2025, 12:11 PM
Maravai LifeSciences Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Biologics Safety Testing Segment Revenue | 62.84M | 64.18M |
| Biologics Safety Testing Segment Revenue Growth | -2.09% | n/a |
| Nucleic Acid Production Segment Revenue | 196.34M | 224.77M |
| Nucleic Acid Production Segment Revenue Growth | -12.65% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Asia Pacific Revenue | 89.38M | 97.44M |
| Asia Pacific Revenue Growth | -8.27% | n/a |
| Emea Revenue | 42.05M | 49.92M |
| Emea Revenue Growth | -15.76% | n/a |
| Latin And Central America Revenue | 662K | 527K |
| Latin And Central America Revenue Growth | +25.62% | n/a |
| North America Revenue | 127.09M | 141.06M |
| North America Revenue Growth | -9.90% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 38.58M | 39.56M | 41.24M | 39.09M | 40.56M | 31.2M | 33.63M | 38.86M | 35.38M | 38.67M | 37.2M | 30.8M | 28.06M | 33.2M | 25.58M | 25.19M | 24.09M | 23.24M | 41.62M | 20.51M | 15.99M | 16.13M | 15.78M |
| Selling, General, and Administrative Revenue Growth | -2.50% | -4.07% | +5.52% | -3.62% | +30.00% | -7.22% | -13.48% | +9.86% | -8.52% | +3.95% | +20.81% | +9.74% | -15.48% | +29.78% | +1.56% | +4.58% | +3.65% | -44.17% | +102.93% | +28.28% | -0.86% | +2.17% | n/a |
| Research and Development Revenue | 4.88M | 4.89M | 4.56M | 4.34M | 5.28M | 5.03M | 4.59M | 4.35M | 4.19M | 4.14M | 5.01M | 5.39M | 4.27M | 3.69M | 9.18M | 1.95M | 1.93M | 2.16M | 2.09M | 1.87M | 1.6M | 3.74M | 979K |
| Research and Development Revenue Growth | -0.12% | +7.17% | +5.00% | -17.79% | +5.01% | +9.53% | +5.68% | +3.65% | +1.18% | -17.28% | -7.01% | +26.09% | +15.67% | -59.77% | +370.97% | +0.93% | -10.72% | +3.44% | +11.99% | +16.75% | -57.26% | +282.43% | n/a |